Primary Fallopian Tube Mullerian Adenosarcoma With Sarcomatous Overgrowth and a Previously Unreported MEIS1-NCOA2 Gene Fusion
article
OA: closed
CC0
AI-generated summary
A 55-year-old patient with abdominal pain and bloating was found to have a primary fallopian tube Mullerian adenosarcoma with sarcomatous overgrowth and a novel MEIS1-NCOA2 gene fusion.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Extrauterine Mullerian adenosarcomas (MA) are rare and often associated with endometriosis. We report a 55-yr-old patient seen in consultation for abdominal pain and bloating. Imaging was suggestive of a left adnexal mass and "peritoneal carcinomatosis". Pathological examination of the specimen revealed a MA arising in the left fallopian tube, with sarcomatous overgrowth, diffuse peritoneal involvement and omental "caking". Next-generation sequencing identified a MEIS1-NCOA2 gene fusion, previously unreported in MA.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (17)
- Müllerian Adenosarcomas With Unusual Growth Patterns via openalex
- Primary extra-uterine and extra-ovarian mullerian adenosarcoma: case report and literature review via openalex
- W2090918533 via openalex
- W2104910696 via openalex
- W2178630176 via openalex
- W2570993395 via openalex
- W2748276225 via openalex
- W2889449832 via openalex
- W2895224490 via openalex
- W2914230008 via openalex
- W2970618655 via openalex
- W2996251860 via openalex
- W3003467184 via openalex
- W3016819253 via openalex
- W3043741511 via openalex
- W6673460995 via openalex
- W2078137082 via openalex
Source provenance
- europepmc
- last seen: 2026-08-22T06:09:51.966504+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:24:43.494969+00:00
- unpaywall
- last seen: 2026-08-22T06:23:50.750314+00:00
License: CC0
· commercial use OK